Peripherex

Company Overview

Snapshot

Founded in January 2021 by Jeffrey Goldberg and Yitzi Kempinski, Peripherex operates with 1–10 employees. The company has secured funding across one round from one investor, BIOLIGHT Life Sciences, to advance its diagnostic and monitoring solutions for peripheral vision impairment.

Business overview

Peripherex specializes in developing a software solution for diagnosing and monitoring peripheral vision impairment, including conditions like glaucoma. Its core technology utilizes sophisticated eye-tracking software that runs on standard personal computers or tablets equipped with a built-in camera, eliminating the need for specialized hardware. This digital healthcare solution serves eye care professionals and patients, operating within the digital medical diagnostics and patient remote monitoring sectors.

Company Intelligence Q&A

What is Peripherex's primary focus?

Peripherex develops a software solution designed to diagnose and monitor peripheral vision impairment, both at home and in clinical settings, to assist with conditions like glaucoma.

Who are the founders of Peripherex?

Peripherex was co-founded by Jeffrey Goldberg and Yitzi Kempinski in January 2021.

What technology does Peripherex utilize?

Peripherex's product employs sophisticated eye-tracking software that can operate on any personal computer or tablet with a built-in camera, removing the need for additional hardware.

What is Peripherex's total funding?

Peripherex has raised a total of $3 million across one funding round.

What markets does Peripherex serve?

Peripherex operates in the digital healthcare market, providing tools for eye care professionals to diagnose and monitor eye diseases.